The Netherlands temporarily suspended AstraZeneca’s COVID-19 vaccine for a second time for people under the age of 60 after a woman who had received the jab died and four other women experienced serious complications, according to a report.
“These are women between 25 and 65 years old. Three patients had extensive pulmonary embolisms. One died and one also had a brain hemorrhage,” Lareb said.
Health officials said a link between the vaccine and the side effects has not yet been established but is being investigated. The complications arose about 7 to 10 days after the people received the vaccine.
It is the first time someone died in the Netherlands after getting the AstraZeneca vaccine, which was previously suspended temporarily in multiple countries in the European Union over blood clot concerns, including in the Netherlands.
Last month, the Netherlands’s Health Ministry halted the administration of AstraZeneca for more than two weeks after serious side effects arose in a small number of people.
France, meanwhile, also said in mid-March it decided to limit the vaccine to people for those aged 55 and older.
“The precautionary measure has no impact on planned vaccinations with AstraZeneca for people 60 and older because reports of possible side effects are mainly seen under 60 years of age,” health officials wrote in the Dutch government statement.
Public Health Minister Hugo de Jonge said it is very important that recent reports in the Netherlands will be properly investigated.
“There should be no doubts whatsoever about the safety of vaccines,” he said. “The crucial question is still whether it concerns complaints after vaccination or due to vaccination. I think it is very important that the Dutch reports are also properly investigated.”
